Search companies

Live

Tuesday, 17 November 2026 · 562 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

BCAL Challenges Genetic Signatures–Microba Deal, While Employee Shares Are Issued

BDX: $0.060 -1.64% · MC: $22M

BCAL Diagnostics, which holds 18.46% of Genetic Signatures, has asked the Takeovers Panel to intervene in Genetic Signatures’ proposed merger with Microba, arguing the deal terms could restrict competing offers and shareholders lack sufficient time and information; the Panel has not decided whether to conduct proceedings. Separately, BCAL issued ordinary shares to employees under its incentive scheme, while performance rights lapsed and options expired.

Source announcements: 2026-11-13 17:29 to 2026-11-13 17:44 Sydney time
Story updated 2026-11-13 17:52 Sydney time
SourcesTOV: GSS - Panel Receives ApplicationApplication for quotation of securities - BDXNotification of cessation of securities - BDXNotification of cessation of securities - BDX
Comments